临床研究

长期维持性透析患者的衰弱现况及其影响因素

  • 李娜 ,
  • 白彝华 ,
  • 蒋红樱 ,
  • 张凤 ,
  • 李萌 ,
  • 杨娇
展开
  • 昆明医科大学第二附属医院肾脏内科 (昆明 650000 )

收稿日期: 2023-08-05

  网络出版日期: 2024-02-22

基金资助

云南省兴滇英才支持计划名医项目(YNWR-MY-2019-075);青年人才项目(YNWR-QNBJ-2020-269)

Frailty of patients with long⁃term maintenance dialysis and its influencing factors

  • Na LI ,
  • Yihua BAI ,
  • Hongying JIANG ,
  • Feng ZHANG ,
  • Meng LI ,
  • Jiao YANG
Expand
  • Department of Nephrology,the Second Affiliated Hospital of Kunming Medical University,Kunming 650000,China

Received date: 2023-08-05

  Online published: 2024-02-22

摘要

目的 分析长期维持性透析(简称:透析)患者的衰弱现况及其影响因素,探讨不同的透析方式和新型冠状病毒感染(COVID-19)复阳与衰弱综合征的相关性。 方法 选取2023年2-6月在肾内科规律透析的患者为研究对象。采用横断面的方法进行调查,收集患者的临床资料,了解患者的透析方式,明确患者是否为COVID-19复阳。使用Fried衰弱表型评估标准将患者分为3组:无衰弱组、衰弱前期组和衰弱综合征组。比较3组患者衰弱表型的临床特征,分析各组患者的临床资料、透析方式及COVID-19复阳与衰弱的相关性,采用多因素logistic回归分析患者发生衰弱综合征的影响因素。 结果 本研究共纳入透析患者246例,其中无衰弱组77例(31.3%),衰弱前期组83例(33.7%),衰弱综合征组86例(35.0%)。衰弱综合征组呈现出高龄、高透析前血肌酐水平、低血清白蛋白水平及合并胸腔积液的特征(均P < 0.05)。血透组和腹透组的衰弱情况比较差异无统计学意义(P = 0.960)。COVID-19复阳患者的衰弱评分较未复阳者高(P < 0.001)。多因素logistic回归显示,年龄、COVID-19复阳、血清白蛋白、透析前血肌酐及胸腔积液与患者发生衰弱综合征独立相关(均P < 0.05)。 结论 透析患者衰弱综合征呈现出较高的发生率,其发生与透析方式无关;高血清白蛋白水平是患者发生衰弱综合征的保护性因素,而COVID-19复阳、高龄、透析前高血肌酐水平及胸腔积液是其发生衰弱综合征的危险因素。

本文引用格式

李娜 , 白彝华 , 蒋红樱 , 张凤 , 李萌 , 杨娇 . 长期维持性透析患者的衰弱现况及其影响因素[J]. 实用医学杂志, 2024 , 40(3) : 330 -335 . DOI: 10.3969/j.issn.1006-5725.2024.03.009

Abstract

Objective To analyze the frailty of patients with long-term maintenance dialysis (MD) and its influencing factors, and to explore the correlation of different dialysis modalities with the re-infection of novel coronavirus infection (COVID-19) and frailty syndrome. Methods Patients with regular dialysis in Nephrology Department of the Second Affiliated Hospital of Kunming Medical University from February to June 2023 were selected. A cross-sectional survey was conducted to collect clinical data of the patients, including dialysis modality(i.e. maintenance hemodialysis, abbreviated as hemodialysis, and continuous ambulatory peritoneal dialysis, abbreviated as peritoneal dialysis),and whether with re-infection of COVID-19. Patients were divided into 3 groups using Fried′s frailty phenotype (FP): non-frailty group, pre-or-intermediate frailty group, and frailty syndrome group. The clinical characteristics of the FP were compared among the three groups. The correlation of frailty with clinical data, dialysis modality, re-infection of COVID-19 in each group was compared. Multifactorial logistic regression was used to analyze the factors influencing the development of frailty syndrome in patients. Results A total of 246 dialysis patients were included in this study, with 77 (31.3%) in the non-frailty group, 83 (33.7%) in the pre-frailty group and 86 (35.0%) in the frailty syndrome group. The frailty syndrome group showed characteristics of advanced age, high pre-dialysis creatinine level, low serum albumin level and combined pleural effusion (all P < 0.05).There was no statistically significant difference in the comparison of frailty between the hemodialysis and peritoneal dialysis group(P = 0.960).COVID-19 re-positive patients had higher frailty score than non-re-positive patients. Multifactor logistic regression showed that age, COVID-19 re-infection of COVID-19, serum albumin, pre-dialysis creatinine, and pleural effusion were factors influencing the development of frailty syndrome in dialysis patients(P < 0.05). Conclusion There is high incidence of frailty syndrome in dialysis patients, and there is no correlation of frailty with dialysis modality. High serum albumin level is a protective factor for the development of frailty syndrome in patients, whereas re-infection of COVID-19, advanced age, high pre-dialysis blood creatinine level and pleural effusion are risk factors for the development of frailty syndrome.

参考文献

1 CHAN G C K, NG J K C, CHOW K M, et al. Progression in physical frailty in peritoneal dialysis patients[J]. Kidney Blood Press Res, 2021,46(3):342-351. doi:10.1159/000515635
2 L?PEZ-MONTES A, MART?EZ-VILLAESCUSA M, P?REZ-RODR?GUEZ A, et al. Frailty, physical function and affective status in elderly patients on hemodialysis[J]. Arch Gerontol Geriatr, 2020,87:103976. doi:10.1016/j.archger.2019.103976
3 LEE S Y, YANG D H, HWANG E, et al. The prevalence, association, and clinical outcomes of frailty in maintenance dialysis patients [J]. J Ren Nutr, 2017,27(2): 106-112. doi:10.1053/j.jrn.2016.11.003
4 ANDERSON B M, QASIM M, CORREA G,et al. Self-reported health change in haemodialysis recipients modulates the effect of frailty upon mortality and hospital admissions: outcomes from a large prospective UK cohort[J]. Nephrol Dial Transplant, 2023,38(5):1297-1308. doi:10.1093/ndt/gfac287
5 YANG D, XIAO Y, CHEN J, et al. COVID-19 and chronic renal disease:clinical characteristics and prognosis[J]. QJM, 2020,113(11):799-805. doi:10.1093/qjmed/hcaa258
6 NADORT E, RIJKERS N, SCHOUTEN R W, et al. Depression, anxiety and quality of life of hemodialysis patients before and during the COVID-19 pandemic[J]. J Psychosom Res, 2022,158:110917. doi:10.1016/j.jpsychores.2022.110917
7 王璐洁,罗纯,黄淑玲,等. 新冠病毒感染者前白蛋白对淋巴细胞的影响:焦虑和超敏C反应蛋白的中介作用[J]. 实用医学杂志, 2023,39(3):273-277. doi:10.3969/j.issn.1006-5725.2023.03.002
8 FRIED L P, TANGEN C M, WALSTON J, et al. Frailty in older adults: evidence for a phenotype[J]. J Gerontol A Biol Sci Med Sci, 2001,56(3): M146-M156. doi:10.1093/gerona/56.3.m146
9 国家卫生健康委员会. 新型冠状病毒感染诊疗方案(试行第十版)〔2023〕4号[EB/OL]. [2023-01-06](2023-01-06)..
10 BOHM C, STORSLEY L, TANGRI N. The assessment of frailty in older people with chronic kidney disease[J]. Curr Opin Nephrol Hypertens, 2015,24(6):498-504. doi:10.1097/mnh.0000000000000163
11 MCADAMS-DEMARCO M A, YING H, THOMAS A G, WARSAME F, et al. Frailty,inflammatory markers, and waitlist mortality among patients with end-stage renal disease in a prospective cohort study[J]. Transplantation, 2018,102(10):1740-1746. doi:10.1097/tp.0000000000002213
12 YE L, TANG X, ZHANG H, et al. Prevalence and risk factors of pre-frailty and frailty in maintenance haemodialysis patients in China: A cross-sectional Study[J]. J Adv Nurs, 2023,79(9):3522-3534. doi:10.1111/jan.15676
13 CHAN G C, NG J K, CHOW K M, et al.Depression does not predict clinical outcome of Chinese peritoneal Dialysis patients after adjusting for the degree of frailty[J]. BMC Nephrol, 2020,21(1):329. doi:10.1186/s12882-020-01994-4
14 郭一丹,张春霞,田茹,等. 老年维持性血液透析患者衰弱综合征的临床特征及其对全因死亡率的影响[J]. 中华肾脏病杂志, 2022,38(7):589-596. doi:10.3760/cma.j.cn441217-20211208-00084
15 JOHANSEN K L, DELGADO C, KAYSEN G A, et al.Frailty among patients receiving hemodialysis: Evolution of components and associations with mortality[J]. J Gerontol A Biol Sci Med Sci,2019,74(3):380-386. doi:10.1093/gerona/gly206
16 DAVENPORT A. Comparison of frailty, sarcopenia and protein energy wasting in a contemporary peritoneal dialysis cohort[J].Perit Dial Int, 2022,42(6):571-577. doi:10.1177/08968608221077462
17 LUO C M, HSIEH M Y, CHENG C H, et al. Association of frailty with thrombosis of hemodialysis vascular access: A prospective taiwanese cohort study[J]. Am J Kidney Dis, 2022,80(3):353-363. doi:10.1053/j.ajkd.2021.12.017
18 KAKITA D, MATSUZAWA R, YAMAMOTO S, et al. Simplified discriminant parameters for sarcopenia among patients undergoing haemodialysis[J]. J Cachexia Sarcopenia Muscle, 2022,13(6):2898-2907. doi:10.1002/jcsm.13078
19 CRUZ-JENTOFT A J, BAHAT G, BAUER J, et al. Sarcopenia: revised European consensus on definition and diagnosis[J]. Age Ageing, 2019,48(1):16-31. doi:10.1093/ageing/afz046
20 ANDERSON B M, WILSON D V, QASIM M, et al. Ultrasound quadriceps muscle thickness is variably associated with frailty in haemodialysis recipients[J]. BMC Nephrol, 2023,24(1):16. doi:10.1186/s12882-022-03043-8
21 CHAN G C, FUNG W W, SZETOC C, et al. From MIA to FIFA: The vicious matrix of frailty,inflammation,fluid overload and atherosclerosis in peritoneal dialysis[J]. Nephrology (Carlton),2023,28(4):215-226. doi:10.1111/nep.14150
22 叶明君,戴勇,汤冬娥,等. 腹膜透析代谢组学研究进展[J]. 实用医学杂志, 2022,38(1):1-6. doi:10.3969/j.issn.1006-5725.2022.01.001
23 CHEN G, ZHANG H, DU X, et al. Comparison of the prevalence and associated factors of cognitive frailty between elderly and middle-young patients receiving maintenance hemodialysis[J].Int Urol Nephrol,2022,54(10):2703-2711. doi:10.1007/s11255-022-03188-3
24 NI LOCHLAINN M, COX N J, WILSON T, et al. Nutrition and Frailty: Opportunities for Prevention and Treatment[J]. Nutrients, 2021,13(7):2349. doi:10.3390/nu13072349
25 IYASERE O U, BROWN E A, JOHANSSON L, et al. Quality of Life and Physical Function in Older Patients on Dialysis: A Comparison of Assisted Peritoneal Dialysis with Hemodialysis[J]. Clin J Am Soc Nephrol, 2016,11(3):423-30.27. doi:10.2215/cjn.01050115
26 GILL T M, GAHBAUER E A, ALLORE H G, et al. Transitions between frailty states among community-living older persons[J]. Arch Intern Med, 2006,166(4):418-423. doi:10.1001/archinte.166.4.418
27 中华医学会老年医学分会,《中华老年医学杂志》编辑委员会.老年人衰弱预防中国专家共识(2022)[J]. 中华老年医学杂志, 2022,41(5):503-511. doi:10.3760/cma.j.issn.0254-9026.2022.05.001
文章导航

/